Virax Biolabs Group Limit... (VRAX)
NASDAQ: VRAX
· Real-Time Price · USD
0.75
0.01 (1.69%)
At close: Aug 15, 2025, 1:18 PM
Virax Biolabs Fail-to-Deliver
Total FTD Shares
1.9K
Below Average
FTD / Avg. Volume
2.02%
Low Impact
1-Year Change
-77.7%
Negative Trend
FTD Chart
As of Jul 14, 2025,
Virax Biolabs Group Limited has
1,896
shares failed to deliver, representing 2.02%
of the average daily volume of
93,790
shares. Over the past year, the monthly average FTD is
38,395
shares, with the current level 95% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 14, 2025 | 0.926 | 1.9K | +13.87% |
| Jun 30, 2025 | 0.7917 | 1.67K | +269.18% |
| May 30, 2025 | 0.9625 | 451 | -89.01% |
| Apr 29, 2025 | 1.04 | 4.11K | +253.88% |
| Mar 27, 2025 | 1.24 | 1.16K | -24.87% |
| Feb 27, 2025 | 1.71 | 1.54K | +86.92% |
| Jan 29, 2025 | 1.92 | 826 | -87.77% |
| Dec 31, 2024 | 2.25 | 6.75K | +237.03% |
| Nov 29, 2024 | 1.97 | 2K | -85.22% |
| Oct 30, 2024 | 2.24 | 13.55K | +4656.14% |
| Sep 30, 2024 | 1.94 | 285 | -99.73% |
| Aug 30, 2024 | 4.66 | 107.52K | +290.79% |
| Jul 29, 2024 | 1.27 | 27.51K | +392.87% |
| Jun 28, 2024 | 1.16 | 5.58K | +42.18% |
| May 31, 2024 | 1.18 | 3.93K | -6.94% |
| Apr 11, 2024 | 0.78 | 4.22K | +58.91% |
| Mar 27, 2024 | 0.705 | 2.65K | -78.69% |
| Feb 29, 2024 | 0.9625 | 12.46K | +32.32% |
| Jan 31, 2024 | 0.82 | 9.41K | +921.04% |
| Dec 29, 2023 | 1.46 | 922 | -94.98% |
| Nov 02, 2023 | 2.6 | 18.36K | +17720.39% |
| Oct 26, 2023 | 2.52 | 103 | +151.22% |
| Sep 22, 2023 | 3.53 | 41 | -49.38% |
| Aug 11, 2023 | 4 | 81 | -98.79% |
| Jul 31, 2023 | 3.97 | 6.72K | -61.97% |
| Jun 30, 2023 | 3.9 | 17.68K | +15541.59% |
| May 30, 2023 | 3.7 | 113 | -95.79% |
| Apr 28, 2023 | 4.18 | 2.68K | -74.33% |
| Mar 29, 2023 | 6.9 | 10.45K | -37.92% |
| Feb 23, 2023 | 7.1 | 16.82K | +55980.00% |
| Jan 31, 2023 | 7.58 | 30 | n/a |